{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:49:53Z","timestamp":1792666193880,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T00:00:00Z","timestamp":1535932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Calpain hyperactivation is implicated in late-stages of neurodegenerative diseases including Alzheimer\u2019s disease (AD). However, calpains are also critical for synaptic function and plasticity, and hence memory formation and learning. Since synaptic deficits appear early in AD pathogenesis prior to appearance of overt disease symptoms, we examined if localized dysregulation of calpain-1 and\/or 2 contributes to early synaptic dysfunction in AD. Increased activity of synaptosomal calpain-2, but not calpain-1 was observed in presymptomatic 1 month old APP<jats:sup>swe<\/jats:sup>\/PS1\u0394E9 mice (a mouse model of AD) which have no evident pathological or behavioural hallmarks of AD and persisted up to 10 months of age. However, total cellular levels of calpain-2 remained unaffected. Moreover, synaptosomal calpain-2 was hyperactivated in frontal neocortical tissue samples of post-mortem brains of AD-dementia subjects and correlated significantly with decline in tests for cognitive and memory functions, and increase in levels of \u03b2-amyloid deposits in brain. We conclude that isoform-specific hyperactivation of calpain-2, but not calpain-1 occurs at the synapse early in the pathogenesis of AD potentially contributing to the deregulation of synaptic signaling in AD. Our findings would be important in paving the way for potential therapeutic strategies for amelioration of cognitive deficits observed in ageing-related dementia disorders like AD.<\/jats:p>","DOI":"10.1038\/s41598-018-31073-6","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T10:15:19Z","timestamp":1535451319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer\u2019s disease mice and correlates with memory deficits in human subjects"],"prefix":"10.1038","volume":"8","author":[{"given":"Faraz","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debajyoti","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reddy Peera","family":"Kommaddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latha","family":"Diwakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruturaj","family":"Gowaikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khader Valli","family":"Rupanagudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayalakshmi","family":"Ravindranath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,3]]},"reference":[{"key":"31073_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/jnc.13713","volume":"138","author":"K Lepeta","year":"2016","unstructured":"Lepeta, K. et al. Synaptopathies: synaptic dysfunction in neurological disorders. J Neurochem 138, 785\u2013805, https:\/\/doi.org\/10.1111\/jnc.13713 (2016).","journal-title":"J Neurochem"},{"key":"31073_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2174\/156720512799361691","volume":"9","author":"Z Wang","year":"2012","unstructured":"Wang, Z., Yang, L. & Zheng, H. Role of APP and A\u03b2 in synaptic physiology. Curr Alzheimer Res 9, 217\u2013226 (2012).","journal-title":"Curr Alzheimer Res"},{"key":"31073_CR3","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1096\/fasebj.8.11.8070630","volume":"8","author":"TC Saido","year":"1994","unstructured":"Saido, T. C., Sorimachi, H. & Suzuki, K. Calpain: new perspectives in molecular diversity and physiological-pathological involvement. FASEB J 8, 814\u2013822 (1994).","journal-title":"FASEB J"},{"key":"31073_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1517\/14728222.2013.766169","volume":"17","author":"M Baudry","year":"2013","unstructured":"Baudry, M., Chou, M. M. & Bi, X. Targeting calpain in synaptic plasticity. Expert Opin Ther Targets 17, 579\u2013592, https:\/\/doi.org\/10.1517\/14728222.2013.766169 (2013).","journal-title":"Expert Opin Ther Targets"},{"key":"31073_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1527-3458.2006.00135.x","volume":"12","author":"A Camins","year":"2006","unstructured":"Camins, A., Verdaguer, E., Folch, J. & Pall\u00e0s, M. Involvement of calpain activation in neurodegenerative processes. CNS Drug Rev 12, 135\u2013148, https:\/\/doi.org\/10.1111\/j.1527-3458.2006.00135.x (2006).","journal-title":"CNS Drug Rev"},{"key":"31073_CR6","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1042\/BST20130201","volume":"41","author":"M McBrayer","year":"2013","unstructured":"McBrayer, M. & Nixon, R. A. Lysosome and calcium dysregulation in Alzheimer\u2019s disease: partners in crime. Biochem Soc Trans 41, 1495\u20131502, https:\/\/doi.org\/10.1042\/BST20130201 (2013).","journal-title":"Biochem Soc Trans"},{"key":"31073_CR7","doi-asserted-by":"publisher","first-page":"728571","DOI":"10.5402\/2012\/728571","volume":"2012","author":"A Ferreira","year":"2012","unstructured":"Ferreira, A. Calpain dysregulation in Alzheimer\u2019s disease. ISRN Biochem 2012, 728571, https:\/\/doi.org\/10.5402\/2012\/728571 (2012).","journal-title":"ISRN Biochem"},{"key":"31073_CR8","doi-asserted-by":"publisher","first-page":"27737","DOI":"10.1074\/jbc.M110.117960","volume":"285","author":"B Liang","year":"2010","unstructured":"Liang, B., Duan, B.-Y., Zhou, X.-P., Gong, J.-X. & Luo, Z.-G. Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Biol Chem 285, 27737\u201327744, https:\/\/doi.org\/10.1074\/jbc.M110.117960 (2010).","journal-title":"J Biol Chem"},{"key":"31073_CR9","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.bbrc.2012.03.026","volume":"420","author":"HT Nguyen","year":"2012","unstructured":"Nguyen, H. T., Sawmiller, D. R., Wu, Q., Maleski, J. J. & Chen, M. Evidence supporting the role of calpain in the \u03b1-processing of amyloid-\u03b2 precursor protein. Biochem Biophys Res Commun 420, 530\u2013535, https:\/\/doi.org\/10.1016\/j.bbrc.2012.03.026 (2012).","journal-title":"Biochem Biophys Res Commun"},{"key":"31073_CR10","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2119\/molmed.2010.00220","volume":"17","author":"A Ferreira","year":"2011","unstructured":"Ferreira, A. & Bigio, E. H. Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies. Mol Med 17, 676\u2013685, https:\/\/doi.org\/10.2119\/molmed.2010.00220 (2011).","journal-title":"Mol Med"},{"key":"31073_CR11","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s12031-013-9966-y","volume":"51","author":"L Gao","year":"2013","unstructured":"Gao, L., Tian, S., Gao, H. & Xu, Y. Hypoxia increases A\u03b2-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice. J Mol Neurosci 51, 138\u2013147, https:\/\/doi.org\/10.1007\/s12031-013-9966-y (2013).","journal-title":"J Mol Neurosci"},{"key":"31073_CR12","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1093\/cercor\/bhu105","volume":"25","author":"A Jer\u00f3nimo-Santos","year":"2014","unstructured":"Jer\u00f3nimo-Santos, A. et al. Dysregulation of TrkB Receptors and BDNF Function by Amyloid-\u03b2 Peptide is Mediated by Calpain. Cereb cortex 25, 3107\u20133121, https:\/\/doi.org\/10.1093\/cercor\/bhu105 (2014).","journal-title":"Cereb cortex"},{"key":"31073_CR13","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3109\/08977194.2015.1080696","volume":"33","author":"A Jer\u00f3nimo-Santos","year":"2015","unstructured":"Jer\u00f3nimo-Santos, A. et al. Brain-derived neurotrophic factor mediates neuroprotection against A\u03b2 -induced toxicity through a mechanism independent on adenosine 2A receptor activation. Growth Factors 33, 298\u2013308, https:\/\/doi.org\/10.3109\/08977194.2015 (2015).","journal-title":"Growth Factors"},{"key":"31073_CR14","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0896-6273(00)80974-5","volume":"19","author":"DR Borchelt","year":"1997","unstructured":"Borchelt, D. R. et al. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron 19, 939\u2013945 (1997).","journal-title":"Neuron"},{"key":"31073_CR15","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1073\/pnas.1112209109","volume":"109","author":"N Sehgal","year":"2012","unstructured":"Sehgal, N. et al. Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci USA 109, 3510\u20133515, https:\/\/doi.org\/10.1073\/pnas.1112209109 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"31073_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.2174\/156720512801322573","volume":"9","author":"DA Bennett","year":"2012","unstructured":"Bennett, D. A., Schneider, J. A., Arvanitakis, Z. & Wilson, R. S. Overview and findings from the religious orders study. Curr Alzheimer Res 9, 628\u2013645 (2012).","journal-title":"Curr Alzheimer Res"},{"key":"31073_CR17","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1089\/ars.2016.6860","volume":"27","author":"F Ahmad","year":"2017","unstructured":"Ahmad, F. et al. Reactive oxygen species-mediated loss of synaptic Akt1 signaling leads to deficient activity-dependent protein translation early in Alzheimer\u2019s disease. Antioxid Redox Signal 27, 1269\u20131280, https:\/\/doi.org\/10.1089\/ars.2016.6860 (2017).","journal-title":"Antioxid Redox Signal"},{"key":"31073_CR18","doi-asserted-by":"publisher","unstructured":"Bermejo, M. K., Milenkovic, M., Salahpour, A. & Ramsey, A. J. Preparation of synaptic plasma membrane and postsynaptic density proteins using a discontinuous sucrose gradient. J Vis Exp e51896, https:\/\/doi.org\/10.3791\/51896 (2014).","DOI":"10.3791\/51896"},{"key":"31073_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s40120-017-0070-z","volume":"6","author":"J-F Jhou","year":"2017","unstructured":"Jhou, J.-F. & Tai, H.-C. The study of postmortem human synaptosomes for understanding Alzheimer\u2019s disease and other neurological disorders: A review. Neurol Ther 6, 57\u201368, https:\/\/doi.org\/10.1007\/s40120-017-0070-z (2017).","journal-title":"Neurol Ther"},{"key":"31073_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0006-8993(81)91086-6","volume":"226","author":"PR Dodd","year":"1981","unstructured":"Dodd, P. R. et al. A rapid method for preparing synaptosomes: Comparison with alternative procedures. Brain Res 226, 107\u2013118 (1981).","journal-title":"Brain Res"},{"key":"31073_CR21","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1128\/MCB.24.6.2499-2512.2004","volume":"24","author":"A Glading","year":"2004","unstructured":"Glading, A. et al. Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation. Mol Cell Biol 24, 2499\u20132512 (2004).","journal-title":"Mol Cell Biol"},{"key":"31073_CR22","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jesp.2013.03.013","volume":"49","author":"C Leys","year":"2013","unstructured":"Leys, C., Ley, C., Klein, O., Bernard, P. & Licata, L. Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median. J Exp Soc Psychol 49, 764\u2013766, https:\/\/doi.org\/10.1016\/j.jesp.2013.03.013 (2013).","journal-title":"J Exp Soc Psychol"},{"key":"31073_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1042\/BJ20120921","volume":"447","author":"RL Campbell","year":"2012","unstructured":"Campbell, R. L. & Davies, P. L. Structure\u2013function relationships in calpains. Biochem J 447, 335\u2013351, https:\/\/doi.org\/10.1042\/BJ20120921 (2012).","journal-title":"Biochem J"},{"key":"31073_CR24","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1042\/bj3280721","volume":"328","author":"H Sorimachi","year":"1997","unstructured":"Sorimachi, H., Ishiura, S. & Suzuki, K. Structure and physiological function of calpains. Biochem J 328, 721\u2013732 (1997).","journal-title":"Biochem J"},{"key":"31073_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/1874467211003010012","volume":"3","author":"KK Cowansage","year":"2010","unstructured":"Cowansage, K. K., LeDoux, J. E. & Monfils, M. H. Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity. Curr Mol Pharmacol 3, 12\u201329 (2010).","journal-title":"Curr Mol Pharmacol"},{"key":"31073_CR26","first-page":"9","volume":"126","author":"BL Hempstead","year":"2015","unstructured":"Hempstead, B. L. Brain-derived neurotrophic factor: Three ligands, many actions. Trans Am Clin Climatol Assoc 126, 9\u201319 (2015).","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"31073_CR27","doi-asserted-by":"publisher","first-page":"9933","DOI":"10.1523\/JNEUROSCI.1907-16.2016","volume":"36","author":"T Saito","year":"2016","unstructured":"Saito, T., Matsuba, Y., Yamazaki, N., Hashimoto, S. & Saido, T. C. Calpain activation in Alzheimer\u2019s model mice is an artifact of APP and presenilin overexpression. J Neurosci 36, 9933\u20139936, https:\/\/doi.org\/10.1523\/JNEUROSCI.1907-16.2016 (2016).","journal-title":"J Neurosci"},{"key":"31073_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13311-014-0327-5","volume":"12","author":"AF Teich","year":"2015","unstructured":"Teich, A. F. et al. Synaptic therapy in Alzheimer\u2019s disease: A CREB-centric approach. Neurotherapeutics 12, 29\u201341, https:\/\/doi.org\/10.1007\/s13311-014-0327-5 (2015).","journal-title":"Neurotherapeutics"},{"key":"31073_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1385\/MN:33:3:215","volume":"33","author":"H-Y Wu","year":"2006","unstructured":"Wu, H.-Y. & Lynch, D. R. Calpain and synaptic function. Mol Neurobiol 33, 215\u2013236, https:\/\/doi.org\/10.1385\/MN:33:3:215 (2006).","journal-title":"Mol Neurobiol"},{"key":"31073_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12035-010-8145-1","volume":"42","author":"S Zadran","year":"2010","unstructured":"Zadran, S., Bi, X. & Baudry, M. Regulation of calpain-2 in neurons: implications for synaptic plasticity. Mol Neurobiol 42, 143\u2013150, https:\/\/doi.org\/10.1007\/s12035-010-8145-1 (2010).","journal-title":"Mol Neurobiol"},{"key":"31073_CR31","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1152\/physrev.1991.71.3.813","volume":"71","author":"DE Croall","year":"1991","unstructured":"Croall, D. E. & DeMartino, G. N. Calcium-activated neutral protease (calpain) system: structure, function, and regulation. Physiol Rev 71, 813\u2013847, https:\/\/doi.org\/10.1152\/physrev.1991.71.3.813 (1991).","journal-title":"Physiol Rev"},{"key":"31073_CR32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.expneurol.2009.09.004","volume":"220","author":"Y Li","year":"2009","unstructured":"Li, Y., Bondada, V., Joshi, A. & Geddes, J. W. Calpain 1 and Calpastatin expression is developmentally regulated in rat brain. Exp Neurol 220, 316\u2013319, https:\/\/doi.org\/10.1016\/j.expneurol.2009.09.004 (2009).","journal-title":"Exp Neurol"},{"key":"31073_CR33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.yexcr.2004.05.021","volume":"299","author":"S Franco","year":"2004","unstructured":"Franco, S., Perrin, B. & Huttenlocher, A. Isoform specific function of calpain 2 in regulating membrane protrusion. Exp Cell Res 299, 179\u2013187, https:\/\/doi.org\/10.1016\/j.yexcr.2004.05.021 (2004).","journal-title":"Exp Cell Res"},{"key":"31073_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.tins.2016.01.007","volume":"39","author":"M Baudry","year":"2016","unstructured":"Baudry, M. & Bi, X. Calpain-1 and calpain-2: The yin and yang of synaptic plasticity and neurodegeneration. Trends Neurosci 39, 235\u2013245, https:\/\/doi.org\/10.1016\/j.tins.2016.01.007 (2016).","journal-title":"Trends Neurosci"},{"key":"31073_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.expneurol.2010.03.007","volume":"224","author":"MB Bevers","year":"2010","unstructured":"Bevers, M. B. et al. RNAi targeting micro-calpain increases neuron survival and preserves hippocampal function after global brain ischemia. Exp Neurol 224, 170\u2013177, https:\/\/doi.org\/10.1016\/j.expneurol.2010.03.007 (2010).","journal-title":"Exp Neurol"},{"key":"31073_CR36","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/sj.bjp.0704661","volume":"135","author":"S Sandmann","year":"2002","unstructured":"Sandmann, S., Prenzel, F., Shaw, L., Schauer, R. & Unger, T. Activity profile of calpains I and II in chronically infarcted rat myocardium\u2013influence of the calpain inhibitor CAL 9961. Br J Pharmacol 135, 1951\u20131958, https:\/\/doi.org\/10.1038\/sj.bjp.0704661 (2002).","journal-title":"Br J Pharmacol"},{"key":"31073_CR37","doi-asserted-by":"publisher","first-page":"18880","DOI":"10.1523\/JNEUROSCI.3293-13.2013","volume":"33","author":"Y Wang","year":"2013","unstructured":"Wang, Y., Briz, V., Chishti, A., Bi, X. & Baudry, M. Distinct roles for \u03bc-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration. J Neurosci 33, 18880\u201318892, https:\/\/doi.org\/10.1523\/JNEUROSCI.3293-13.2013 (2013).","journal-title":"J Neurosci"},{"key":"31073_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbi.2014.08.003","volume":"44","author":"Y Zang","year":"2014","unstructured":"Zang, Y. et al. Calpain-2 contributes to neuropathic pain following motor nerve injury via up-regulating interleukin-6 in DRG neurons. Brain Behav Immun 44, 37\u201347, https:\/\/doi.org\/10.1016\/j.bbi.2014.08.003 (2014).","journal-title":"Brain Behav Immun"},{"key":"31073_CR39","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1128\/MCB.02243-05","volume":"26","author":"H Shao","year":"2006","unstructured":"Shao, H. et al. Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation. Mol Cell Biol 26, 5481\u20135496, https:\/\/doi.org\/10.1128\/MCB.02243-05 (2006).","journal-title":"Mol Cell Biol"},{"key":"31073_CR40","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1523\/JNEUROSCI.5120-09.2010","volume":"30","author":"S Zadran","year":"2010","unstructured":"Zadran, S. et al. Brain-derived neurotrophic factor and epidermal growth factor activate neuronal m-calpain via mitogen-activated protein kinase-dependent phosphorylation. J Neurosci 30, 1086\u20131095, https:\/\/doi.org\/10.1523\/JNEUROSCI.5120-09.2010 (2010).","journal-title":"J Neurosci"},{"key":"31073_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fnagi.2015.00245","volume":"7","author":"P Faucher","year":"2016","unstructured":"Faucher, P., Mons, N., Micheau, J., Louis, C. & Beracochea, D. J. Hippocampal injections of oligomeric amyloid \u03b2-peptide (1\u201342) induce selective working memory deficits and long-lasting alterations of ERK signaling pathway. Front Aging Neurosci 7, 245, https:\/\/doi.org\/10.3389\/fnagi.2015.00245 (2016).","journal-title":"Front Aging Neurosci"},{"key":"31073_CR42","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/01.jnen.0000199599.63204.6f","volume":"65","author":"B Webster","year":"2006","unstructured":"Webster, B. et al. Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. J Neuropathol Exp Neurol 65, 142\u2013151, https:\/\/doi.org\/10.1097\/01.jnen.0000199599.63204.6f (2006).","journal-title":"J Neuropathol Exp Neurol"},{"key":"31073_CR43","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0006-8993(91)90722-8","volume":"558","author":"S Shimohama","year":"1991","unstructured":"Shimohama, S. et al. Presence of calpain II immunoreactivity in senile plaques in Alzheimer\u2019s disease. Brain Res 558, 105\u2013108 (1991).","journal-title":"Brain Res"},{"key":"31073_CR44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.jalz.2014.06.003","volume":"11","author":"C Laske","year":"2015","unstructured":"Laske, C. et al. Increased cerebrospinal fluid calpain activity and microparticle levels in Alzheimer\u2019s disease. Alzheimer\u2019s Dement 11, 465\u2013474, https:\/\/doi.org\/10.1016\/j.jalz.2014.06.003 (2015).","journal-title":"Alzheimer\u2019s Dement"},{"key":"31073_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep08187","volume":"5","author":"N Jin","year":"2015","unstructured":"Jin, N. et al. Truncation and activation of GSK-3\u03b2 by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer\u2019s disease. Sci Rep 5, 8187, https:\/\/doi.org\/10.1038\/srep08187 (2015).","journal-title":"Sci Rep"},{"key":"31073_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s40478-016-0299-2","volume":"4","author":"K Kurbatskaya","year":"2016","unstructured":"Kurbatskaya, K. et al. Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer\u2019s disease brain. Acta Neuropathol Commun 4, 34, https:\/\/doi.org\/10.1186\/s40478-016-0299-2 (2016).","journal-title":"Acta Neuropathol Commun"},{"key":"31073_CR47","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/1873-3468.12617","volume":"591","author":"N Jin","year":"2017","unstructured":"Jin, N. et al. C-terminal truncation of GSK-3\u03b2 enhances its dephosphorylation by PP2A. FEBS Lett 591, 1053\u20131063, https:\/\/doi.org\/10.1002\/1873-3468.12617 (2017).","journal-title":"FEBS Lett"},{"key":"31073_CR48","doi-asserted-by":"publisher","first-page":"15219","DOI":"10.1074\/jbc.M115.645507","volume":"290","author":"N Jin","year":"2015","unstructured":"Jin, N. et al. Truncation and activation of dual specificity tyrosine phosphorylation-regulated kinase 1A by Calpain I: A molecular mechanism linked to Tau pathology in Alzheimer disease. J Biol Chem 290, 15219\u201315237, https:\/\/doi.org\/10.1074\/jbc.M115.645507 (2015).","journal-title":"J Biol Chem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31073-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31073-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31073-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T09:00:35Z","timestamp":1671613235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-31073-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,3]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["31073"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-31073-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,3]]},"assertion":[{"value":"23 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13119"}}